Kalos Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-14,050
| Closed | -$27K | – | 131 |
|
|
2022
Q2 | $27K | Sell |
14,050
-500
| -3% | -$961 | 0.04% | 131 |
|
|
2022
Q1 | $43K | Buy |
+14,550
| New | +$43K | 0.03% | 167 |
|
|
2021
Q4 | – | Sell |
-15,550
| Closed | -$77K | – | 288 |
|
|
2021
Q3 | $77K | Sell |
15,550
-4,000
| -20% | -$19.8K | 0.02% | 285 |
|
|
2021
Q2 | $127K | Hold |
19,550
| – | – | 0.05% | 250 |
|
|
2021
Q1 | $138K | Sell |
19,550
-2,500
| -11% | -$17.6K | 0.04% | 277 |
|
|
2020
Q4 | $138K | Sell |
22,050
-2,500
| -10% | -$15.6K | 0.06% | 234 |
|
|
2020
Q3 | $136K | Sell |
24,550
-500
| -2% | -$2.77K | 0.06% | 213 |
|
|
2020
Q2 | $130K | Hold |
25,050
| – | – | 0.05% | 201 |
|
|
2020
Q1 | $78K | Hold |
25,050
| – | – | 0.03% | 193 |
|
|
2019
Q4 | $100K | Hold |
25,050
| – | – | 0.04% | 191 |
|
|
2019
Q3 | $107K | Sell |
25,050
-5,000
| -17% | -$21.4K | 0.04% | 183 |
|
|
2019
Q2 | $119K | Buy |
30,050
+3,483
| +13% | +$13.8K | 0.05% | 181 |
|
|
2019
Q1 | $142K | Buy |
26,567
+2,117
| +9% | +$11.3K | 0.09% | 144 |
|
|
2018
Q4 | $160K | Buy |
24,450
+11,000
| +82% | +$72K | 0.08% | 171 |
|
|
2018
Q3 | $115K | Buy |
+13,450
| New | +$115K | 0.06% | 155 |
|